To further identify the biological role of DGCR5 in tumorigenesis of ESCC in vivo, we established a cell-derived xenograft (CDX) model by subcutaneously injecting Kyse170 cells with vector or interfered DGCR5 into 5-week-old nude mice. The gene discussed is DGCR5; the disease is esophageal squamous cell carcinoma.